uBiome, a San Franscisco-based company that makes a direct-to-consumer microbial genomic testing kit, has raised $22m in a Series B funding round from 8VC, Slow Ventures, Stanford's StartX Fund and other angel investors. The startup is developing an app to help people identify microbes they might be exposed to, such as those found on their skin or in the air around them. By making gut health testing faster and easier, uBiome will unquestionably have a massive impact," said Joe Lonsdale, founding partner at 8VC.
uBiome, a San Franscisco-based company that makes a direct-to-consumer microbial genomic testing kit, has raised $22m in a Series B funding round from 8VC, Slow Ventures, Stanford's StartX Fund and other angel investors. The screening kit, SmartGut, will enable consumers and doctors to identify microorganisms through DNA sequencing and give them actionable information about their gut microbiome to improve health. "By making gut health testing faster and easier, uBiome will unquestionably have a massive impact," said Joe Lonsdale, founding partner at 8VC.